Intranasal Insulin for COVID-19-related Smell Loss

PHASE3CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

November 25, 2021

Study Completion Date

December 20, 2021

Conditions
AnosmiaSmell LossParaosmiaHyposmiaCOVID-19
Interventions
DRUG

Insulin

Gelfoam® cottonoids soaked in 40 IU of NPH insulin were placed on the nasal roof (between the nasal septum and the middle meatus) of each nostril. These remained in place for 15 minutes and were later removed. This procedure was performed in three visits one week apart. During the fourth and last visit (one week after the previous visit), olfaction was reevaluated using the measures previously described.

Trial Locations (1)

03920

Universidad Panamerican, Mexico City

All Listed Sponsors
lead

Universidad Panamericana

OTHER

NCT05461365 - Intranasal Insulin for COVID-19-related Smell Loss | Biotech Hunter | Biotech Hunter